Fragrance avoidance
No fragrance-linked caution surfaced in the current profile.
This ingredient does not currently read as a fragrance-linked driver in the published evidence and hazard profile.
Route: INFILTRATION; Dosage form: INJECTION, SOLUTION; Potency: 0.01 %w/v
Concern score
The concern value reflects this ingredient's chemical identity — its hazard profile from the published classifications and regulatory status below — not the safety of a product it appears in. A score near 40 is the baseline for ingredients with no specific signal (water scores 40 by design), so a mid-range value is not a safety verdict.
Concern score 5/100 (low) · high confidence.
Prevalence of EDETATE CALCIUM DISODIUM in our catalog (fda_ndc).
Products
1
Catalog
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Fragrance avoidance
No fragrance-linked caution surfaced in the current profile.
This ingredient does not currently read as a fragrance-linked driver in the published evidence and hazard profile.
The published evidence profile currently shaping this ingredient record.
Primary documents currently linked to this ingredient record.
Structured claim signals pulled from linked ingredient research.
Published jurisdiction-level classifications and regulatory designations for this ingredient.
US
FDA
Route: INFILTRATION; Dosage form: INJECTION, SOLUTION; Potency: 0.01 %w/v
US
FDA
Route: INTRA-ARTERIAL; Dosage form: INJECTION; Maximum daily exposure: 25 mg
US
FDA
Route: INTRA-ARTERIAL; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 25 mg
Océan Blue Lemonade
Calypso
US
FDA
Route: INTRAMUSCULAR; Dosage form: INJECTION; Potency: 0.05 %w/v
US
FDA
Route: INTRATHECAL; Dosage form: INJECTION; Potency: 2.16 mg
US
FDA
Route: INTRAVASCULAR; Dosage form: INJECTION; Potency: 100 mg
US
FDA
Route: INTRAVASCULAR; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 108 mg
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION; Maximum daily exposure: 25 mg
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 108 mg
US
FDA
Route: INTRAVESICAL; Dosage form: SOLUTION; Potency: 0.11 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Potency: NA
US
FDA
Route: ORAL; Dosage form: CONCENTRATE; Potency: 0.25 mg/1ml
US
FDA
Route: ORAL; Dosage form: POWDER, FOR SOLUTION; Potency: 0.22 mg
US
FDA
Route: ORAL; Dosage form: POWDER, FOR SUSPENSION; Potency: NA
US
FDA
Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 4 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FILM COATED; Potency: 0.4 mg
US
FDA
Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING; Potency: 0.78 mg
US
FDA
Route: SUBCUTANEOUS; Dosage form: INJECTION; Potency: 5 mg
US
FDA
Route: SUBCUTANEOUS; Dosage form: INJECTION, SOLUTION; Potency: 0.06 %w/v
US
FDA
Route: TOPICAL; Dosage form: OINTMENT; Maximum daily exposure: 2 mg
US
FDA
Route: TOPICAL; Dosage form: SOLUTION; Potency: 0.01 %w/v
US
FDA
Route: URETHRAL; Dosage form: SOLUTION; Potency: 0.01 %w/v
US
FDA
FDA NDC lists this ingredient in 1 active drug products and 1 total products.
US
FDA
openFDA substance registry classifies this ingredient as chemical.